Filed before 2025Filed 22 July 2021
Tallac Therapeutics, Inc. has sold $61.6M so far
Tallac Therapeutics, Inc., a health care company based in Burlingame, CA, has sold $61.6M so far in its equity round, according to a filing dated 22 July 2021.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 22 July 2021
- First filed
- 27 July 2020
- Round
- Equity round (amended filing)
- Amount sold
- $61.6M
- Offering size
- $61.6M
- Investors so far
- 12
- Based in
- Burlingame, CA
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
2 directors of this company are named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 85% of the 2,220 tracked raises with an amount filed in 2021, and than 86% of the 200 in health care.
Tallac Therapeutics, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 22 Jul 2021 | Amended filing | $61.6M | This raise |
| 27 Jul 2020 | New filing | $21.2M | This raise |
More with Lightstone Ventures on the board
- Imperative Care, Inc.$111M
- Apreo Health, Inc.$81.8M
- Allay Therapeutics, Inc.$45M
- Cala Health, Inc.$48.2M
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.